Table 1 (abstract P137). Univariate comparison of the characteristics of patients with ≤4 headache days per month (super responders) vs patients who had a decrease <30% in headache days per month (non-responders)

Age, median (IQR)

54.4 (53-56)

47 (45-54)

0.638

-

Female sex, n (%)

21 (77.6)

37 (92.5)

0.083

0.52 (0.20-1.34)

Migraine years, median (IQR)

44.5 (38-51)

27 (23-45)

0.144

-

Chronic migraine duration (months), median (IQR)

8.5 (5-12)

120 (24-120)

0.056

-

Monthly headache days, median (IQR)

30 (23.5-30)

30 (25-30)

0.146

-

Medication overuse, n (%)

17 (63.0)

33 (84.6)

0.044

1.84 (1.07-3.16)

Allodynia, n (%)

10 (41.7)

16 (47.1)

0.684

0.91 (0.59-1.41)

Unilateral headache, n (%)

12 (44.4)

16 (41.0)

0.782

1.06 (0.70-1.60)

Throbbing headache, n (%)

18 (66.7)

21 (53.8)

0.298

1.24 (0.84-1.84)

Baseline MIDAS score, median (IQR)

106.5 (81-132)

92 (41-203)

0.923

-

Baseline HIT-6 score, median (IQR)

77 (72-82)

71 (64-72)

0.154

-

Baseline VAS score, median (IQR)

9.5 (9-10)

10 (8-10)

0.301

-

Baseline BDI score, median (IQR)

33.5 (30-37)

9 (6-21)

0.051

-

Baseline GAD-7 score, median (IQR)

19 (14-24)

4 (3-12)

0.051

-